Transforming Operations with AI-Powered Internal Applications
Rethinking healthcare infrastructure through software engineering first principles.
Accelerating Patient Access to the Right Medications
Calibrate’s mission is to make metabolic health accessible and sustainable. Its digital weight-loss program combines GLP-1 medications (e.g. Ozempic, Wegovy) with coaching to address obesity. These drugs are highly effective but costly, and many insurers require detailed prior authorizations (PAs).
By partnering with Develop Health, Calibrate transformed its PA operations from a manual and costly bottleneck into an automated, scalable system that delivers better and faster outcomes for patients, providers and the business itself.
Key Challenges
Timely access to medication is essential for Calibrate members who rely on these therapies for real health improvement. Manual PA workflows lead to slowed initiation, increased burden, and delayed treatment when patients need it most.
Manual work slowed down time-to-initiation and time-to-decision.
Administrative burden increased operating costs.
Patients often faced delays in getting their first-choice medication.
Calibrate needed a solution that could remove friction, cut costs, and keep patients on the best path for long-term success.
The Solution: Develop Health’s AI-Powered PA Platform
Calibrate integrated Develop Health’s end-to-end automation for PA workflows. The result? A significant improvement in approval rates, speed and cost efficiency.
The percentage of approved PAs steadily climbed, as shown in the chart below, representing a meaningful increase in patients getting the medications they need.
About this image
Lower Administrative Costs
X% of questions on Calibrate’s PAs are now answered by AI in under Y seconds, at a cost of just Z cents per question or per patient fill.
Greater Operational Scale
These efficiencies enabled Calibrate to handle more volume, leading to an XX% lift in PA submissions processed over the last 12 months.
Faster Decision-Making
Time to initiation of a PA is now just XX seconds, compared to X days before. Average time to determination is now under 1 day, versus Y days previously.
Broader Payer Coverage
Y% of Calibrate PAs now go through Develop Health across Z payers, with fax and human fallback ensuring full coverage even beyond ePA channels.
Proactive Renewals
Develop Health now handles proactive submissions and renewals, saving ZZZ reactive PA initiations per year.
Actionable Real-Time Data
Calibrate receives XX webhooks per month, enabling the team to stay closely connected to the status of every PA and keep patients informed throughout the process.
The Outcome: Better Access, Better Health
More Patients on First-Choice Medications
XX% of patients now receive their first drug of choice. More patients get the care that’s best for them, leading to ~19% average sustained weight loss at 36 months.
Better Adherence
XX% of patients stay on their initial drug of choice at 6 months, compared to a Y% benchmark, a critical step toward long-term success.More PAs ProcessedCalibrate now processes more PAs, with a XX PA submission increase in the last 12 months.
